Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04081207
Other study ID # 1R15DC017280-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date December 2021

Study information

Verified date September 2019
Source University of Cincinnati
Contact Aimee Dietz, PhD
Phone 513-558-8551
Email aimee.dietz@uc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The currently available interventions only partially restore language abilities in patients with post-stroke aphasia; preventing successful reintegration into society. This study will increase our knowledge of how we can use assistive technology interventions to help people with aphasia restore language function. Further, this project will help us identify regions of the brain responsible for these changes.


Description:

In aphasia rehabilitation, usual care is focused on helping people recuperate as much of their pre-stroke language capacity as possible.Typically, usual care is a non-standardized therapy that is tailored to the specific needs of the person with aphasia.Once a person reaches a plateau in language recovery, AAC is implemented with a focus on circumventing, or compensating for the communication challenges associated with aphasia.

The ability of people with aphasia to (1) recover language function well-into the chronic phase of stroke recovery and (2) self-cue to promote word retrieval during anomic events offer the solution for how AAC could be employed as a dual-purpose tool to augment language recovery and compensate for deficits. This approach, however, this requires a shift in how AAC is implemented. With the goal of language recovery, treatment needs to focus on instructing people with aphasia how to use AAC as a mechanism for self-cueing, rather than as a tool to replace speaking. Based on our pilot data, we hypothesize that this novel method to AAC implementation will promote language recovery by coupling the canonical language and visual processing neural networks.

This work will also contribute to our ability to identify, a priori, who will respond to this particular AAC intervention and who will not, by combining neuroimaging with behavioral and clinical data. This has the potential to reduce the cost of healthcare for stroke recovery by implementing the most effective treatment possible. Importantly, when we identify non-responders, this will allow us to construct a profile and identify features of the AAC treatment that require adjustment to meet their unique needs.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 2021
Est. primary completion date August 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- at least 18 years old

- native speaker of american English

- compatible for 3 Tesla MRI

- Ischemic, left middle cerebral artery stroke

- at least 12 months post stroke

- pass hearing screening

- pass vision screening

- diagnosis of aphasia on the Western Aphasia Bedside Screen

- ability to produce 5-10 intelligible words

- no more than a moderate apraxia of speech or dysarthria

- minimal or no AAC/iPad experience

- written consent by self or guardian

Exclusion Criteria:

- fails to meet the above

- Underlying degenerative or metabolic disorder or supervening medical illness

- Severe depression or other psychiatric disorder

- Report of pregnancy by women of childbearing age

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
AAC for Language Recovery (AAC-LaRc)
iPads will be programmed with a personalized communication application (app) and a structured 4-step intervention will be employed to instruct patients how to cue themselves during anomic events via pictures, text, or speak buttons.

Locations

Country Name City State
United States University of Cincinnati Cincinnati Ohio

Sponsors (2)

Lead Sponsor Collaborator
University of Cincinnati Children's Hospital Medical Center, Cincinnati

Country where clinical trial is conducted

United States, 

References & Publications (1)

Aimee Dietz, Jennifer Vannest, Thomas Maloney, Mekibib Altaye, Scott Holland & Jerzy P Szaflarski (2018) The feasibility of improving discourse in people with aphasia through AAC: clinical and functional MRI correlates, Aphasiology, 32:6, 693-719, DOI: 10.1080/02687038.2018.1447641

Outcome

Type Measure Description Time frame Safety issue
Primary Western Aphasia Battery-Revised Aphasia Quotient a diagnostic tool used to determine aphasia type and severity 3 years
Primary Visual Regions of Interest Activation intensity A functional magnetic resonance imaging (fMRI) measure to indicate change in brain involvement during resting state and language tasks. 3 years
Primary Connectivity Indices Connectivity indices reflect the temporal correlation between canonical language and visual regions of interest during language and resting state fMRI tasks. 3 years
Secondary Motor-Free Visual Perception Test-4 The Motor-Free Visual Perception Test-4 assesses visual perceptual ability without requiring motor responses. 3 years
Secondary Discourse Analyses We will calculate percentage of counted words, mazes, correct information units, t-units, during personal story retells with and without the AAC support. 3years
Secondary Communication analyses We will calculate percentage of communication conveyed via pictures, text boxes, and speak button during personal story retells with and without the iPad AAC support. 3 years
Secondary Stroke and Aphasia Quality of Life-39 (SAQOL-39) The SAQOL-39 is a valid and reliable measure of health related quality of life, post-stroke that uses an aphasia friendly 5 point Likert scale format. 3 years
Secondary Communication Effectiveness Index (CETI) The CETI measures functional communication scenarios that caregivers rate the ability of the patient to complete tasks, as compared to before their stroke, via a 10 cm visual analogue scale. 3 years
Secondary Fractional Anisotropy (FA) FA is a value of diffusion and reflects white matter density and myelination. We will examine the following tracts: (1) superior, (2) inferior fronto-occipital, (3) middle longitudinal, (4) inferior longitudinal fasciculus, (5) arcuate, and (6) uncinate 3 years
Secondary Mean Diffusivity (MD) MD is used to map tracts and serves as a measure of health or disease in white matter. We will determine the MD for the following pathways: (1) superior, (2) inferior fronto-occipital, (3) middle longitudinal, (4) inferior longitudinal fasciculus, (5) arcuate, and (6) uncinate 3 years
Secondary Language Lateralization Indices (LI) LI is a measure that reflects hemispheric dominance for language, while accounting for lesioned tissue. 3 years
See also
  Status Clinical Trial Phase
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Recruiting NCT03929432 - Treatment Outcomes With tDCS in Post-Stroke Aphasia N/A
Completed NCT03662295 - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed NCT03679637 - Tablet-based Aphasia Therapy in the Acute Phase After Stroke N/A
Completed NCT03228264 - A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia. N/A
Completed NCT03550092 - Analysis of Brain Activity to Uncover Brain-behavior Relationships Related to Therapy Outcomes in Aphasia N/A
Suspended NCT04290988 - Circuitry Assessment and Reinforcement Training Effects on Recovery N/A
Recruiting NCT05969548 - pBFS-guided cTBS at Different Doses for Aphasia After Stroke N/A
Recruiting NCT04138940 - Modulating Intensity and Dosage of Aphasia Scripts N/A
Terminated NCT02249819 - Evaluating Anodal tDCS Preceding Aphasia Therapy Phase 1/Phase 2
Completed NCT01654029 - Patient Centred Communication Intervention N/A
Completed NCT00843427 - fMRI of Language Recovery Following Stroke in Adults N/A
Active, not recruiting NCT00227461 - Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients. Phase 1
Completed NCT03773419 - Improving Electronic Written Communication in Aphasia N/A
Not yet recruiting NCT04142866 - Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia N/A
Suspended NCT04048668 - tDCS to Treat Subacute Aphasia N/A
Completed NCT02226796 - Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia N/A
Completed NCT01163461 - Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia N/A
Recruiting NCT03309930 - Narrative Comprehension by People With Acquired Brain Injury N/A

External Links